Clinical Trials in Michigan

Michigan is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Michigan and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 322 actively recruiting studies with Michigan sites out of 322 registered in total. The busiest research areas in Michigan are Advanced Solid Tumors, Small Cell Lung Cancer, Parkinson Disease. Leading sponsors running trials in the state include University of Michigan, National Cancer Institute (NCI), AstraZeneca. By stage, Michigan trials break down as Phase 1 (65), Phase 2 (105), Phase 3 (96), Phase 4 (10).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Frequently Asked Questions — Clinical Trials in Michigan